Hypoxia Increases Resistance of Human Pancreatic Cancer Cells to Apoptosis Induced by Gemcitabine

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-03-0488
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells

British Journal of Cancer
Cancer ResearchOncology
2008English

Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity

Acta Pharmacologica Sinica
MedicinePharmacology
2009English

SKP2 Confers Resistance of Pancreatic Cancer Cells Towards TRAIL-induced Apoptosis

International Journal of Oncology
Cancer ResearchOncology
2010English

Knockdown of POLA2 Increases Gemcitabine Resistance in Lung Cancer Cells

BMC Genomics
BiotechnologyGenetics
2016English

Emodin Reverses Gemcitabine Resistance in Pancreatic Cancer Cells via the Mitochondrial Apoptosis Pathway in Vitro

International Journal of Oncology
Cancer ResearchOncology
2011English

Loss of PDPK1 Abrogates Resistance to Gemcitabine in Label-Retaining Pancreatic Cancer Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

Enhancement of Hypoxia-Induced Apoptosis of Human Breast Cancer Cells via STAT5b by Momilactone B

International Journal of Oncology
Cancer ResearchOncology
1992English

Paclitaxel-Induced Apoptosis Is Blocked by Camptothecin in Human Breast and Pancreatic Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy